Need help finding what you are looking for?
Contact Us
PUBLISHER: KBV Research | PRODUCT CODE: 1335503
PUBLISHER: KBV Research | PRODUCT CODE: 1335503
LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market Size, Share & Industry Trends Analysis Report By Product, By End User, By Testing Type, By Technology, By Country and Growth Forecast, 2023 - 2030
PUBLISHED:
PAGES: 136 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The Latin America, Middle East and Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market would witness market growth of 11.6% CAGR during the forecast period (2023-2030).
The most effective diagnostics for CT and NG screening and diagnosis are nucleic acid amplification tests (NAATs), which have a high level of sensitivity. A wide variety of specimen forms are appropriate for detecting NG infections, but for CT detection, vaginal swabs for women and first-catch urine for males are preferable for NAATs. The Centers for Disease Control and Prevention (CDC) recommendations acknowledge the use of endocervical samples in addition to these specimen categories. The ability to detect infection in both symptomatic and asymptomatic patients, including pregnant and non-pregnant women, is a critical component of a successful CT/NG screening test, and accepting a variety of specimen types maximizes clinician and client convenience, a key strategy to increase screening coverage.
The two distinct bacterial pathogens that cause CT/NG infections reach the host tissue in the urethra, anus, or throat only through sexual contact. Once inside the urethra, the bacteria infiltrate or attach to host tissue, triggering an inflammatory response often followed by a purulent discharge that the patient might observe. Then, both males' and females' urogenital tracts could become infected due to these microorganisms. Inflammation could result in issues with the prostate in males and the urethra, cervix, fallopian tubes, and uterus in women, perhaps leading to infertility in both sexes. In addition to discomfort, bleeding, or discharge from the anus, patients may also have ulcers, redness, or lesions in the mouth. The majority of patients, however, have no symptoms at all.
The prevalence of STDs or STIs are gaining a high momentum in the African region, which is leading to various health problems and serious complications. When compared to other regions, Sub-Saharan Africa has the highest annual STD cases. Infect papillomaviruses herpes simplex virus and the human papillomavirus are becoming more common in Sub-Saharan Africa. While there are more than 20 bacteria that cause STDs, they mostly manifest themselves in four syndromes and can thus be treated syndromically. Many government and major healthcare organizations are working together to improve the state of medical services, especially STD treatment across this region.
The Brazil market dominated the LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $46.4 million by 2030. The Argentina market is showcasing a CAGR of 12.2% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 11.3% during (2023 - 2030).
Based on Product, the market is segmented into Assays & Kits, and Instruments & Analyzers. Based on End User, the market is segmented into Diagnostic Laboratories, Hospitals & Clinics, and Others. Based on Testing Type, the market is segmented into Lab Tests, and PoC Tests. Based on Technology, the market is segmented into Isothermal Nucleic Acid Amplification Technology, Polymerase Chain Reaction, Immunodiagnostics, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Becton, Dickinson and Company, ZeptoMetrix LLC (Antylia Scientific), Danaher Corporation, F. Hoffmann-La Roche Ltd., Hologic, Inc., Thermo Fisher Scientific, Inc., Bayer AG, Qiagen N.V. and Siemens AG.
Scope of the Study
Market Segments covered in the Report:
By Product
- Assays & Kits
- Instruments & Analyzers
By End User
- Diagnostic Laboratories
- Hospitals & Clinics
- Others
By Testing Type
- Lab Tests
- PoC Tests
By Technology
- Isothermal Nucleic Acid Amplification Technology
- Polymerase Chain Reaction
- Immunodiagnostics
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- Abbott Laboratories
- Becton, Dickinson and Company
- ZeptoMetrix LLC (Antylia Scientific)
- Danaher Corporation
- F. Hoffmann-La Roche Ltd.
- Hologic, Inc.
- Thermo Fisher Scientific, Inc.
- Bayer AG
- Qiagen N.V.
- Siemens AG
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, by Product
- 1.4.2 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, by End User
- 1.4.3 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, by Testing Type
- 1.4.4 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, by Technology
- 1.4.5 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market at a Glance
- 2.1 Key Highlights
Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.1.1 Overview
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.3 Porter's Five Forces Analysis
Chapter 4. LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
- 4.1 LAMEA Assays & Kits Market by Country
- 4.2 LAMEA Instruments & Analyzers Market by Country
Chapter 5. LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
- 5.1 LAMEA Diagnostic Laboratories Market by Country
- 5.2 LAMEA Hospitals & Clinics Market by Country
- 5.3 LAMEA Others Market by Country
Chapter 6. LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
- 6.1 LAMEA Lab Tests Market by Country
- 6.2 LAMEA PoC Tests Market by Country
Chapter 7. LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
- 7.1 LAMEA Isothermal Nucleic Acid Amplification Technology Market by Country
- 7.2 LAMEA Polymerase Chain Reaction Market by Country
- 7.3 LAMEA Immunodiagnostics Market by Country
- 7.4 LAMEA Others Market by Country
Chapter 8. LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Country
- 8.1 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
- 8.1.1 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
- 8.1.2 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
- 8.1.3 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
- 8.1.4 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
- 8.2 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
- 8.2.1 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
- 8.2.2 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
- 8.2.3 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
- 8.2.4 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
- 8.3 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
- 8.3.1 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
- 8.3.2 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
- 8.3.3 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
- 8.3.4 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
- 8.4 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
- 8.4.1 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
- 8.4.2 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
- 8.4.3 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
- 8.4.4 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
- 8.5 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
- 8.5.1 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
- 8.5.2 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
- 8.5.3 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
- 8.5.4 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
- 8.6 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
- 8.6.1 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
- 8.6.2 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
- 8.6.3 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
- 8.6.4 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
- 8.7 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
- 8.7.1 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
- 8.7.2 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
- 8.7.3 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
- 8.7.4 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
Chapter 9. Company Profiles
- 9.1 Abbott Laboratories
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Segmental and Regional Analysis
- 9.1.4 Research & Development Expense
- 9.1.5 Recent strategies and developments:
- 9.1.5.1 Trials & Approvals:
- 9.1.6 SWOT Analysis
- 9.2 Becton, Dickinson, and Company
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Segmental and Regional Analysis
- 9.2.4 Research & Development Expense
- 9.2.5 Recent strategies and developments:
- 9.2.5.1 Product Launches and Product Expansions:
- 9.2.6 SWOT Analysis
- 9.3 ZeptoMetrix LLC (Antylia Scientific)
- 9.3.1 Company Overview
- 9.3.2 SWOT Analysis
- 9.4 Danaher Corporation
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Segmental and Regional Analysis
- 9.4.4 Research & Development Expense
- 9.4.5 SWOT Analysis
- 9.5 F. Hoffmann-La Roche Ltd.
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Segmental and Regional Analysis
- 9.5.4 Research & Development Expense
- 9.5.5 Recent strategies and developments:
- 9.5.5.1 Trials & Approvals:
- 9.5.6 SWOT Analysis
- 9.6 Hologic, Inc.
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Segmental and Regional Analysis
- 9.6.4 Research & Development Expenses
- 9.6.5 SWOT Analysis
- 9.7 Thermo Fisher Scientific, Inc.
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Segmental and Regional Analysis
- 9.7.4 Research & Development Expenses
- 9.7.5 SWOT Analysis
- 9.8 Bayer AG
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Segmental and Regional Analysis
- 9.8.4 Research & Development Expense
- 9.8.5 SWOT Analysis
- 9.9 Qiagen N.V.
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Regional Analysis
- 9.9.4 Research & Development Expense
- 9.9.5 SWOT Analysis
- 9.10. Siemens AG
- 9.10.1 Company Overview
- 9.10.2 Financial Analysis
- 9.10.3 Segmental and Regional Analysis
- 9.10.4 Research & Development Expense
- 9.10.5 SWOT Analysis
LIST OF TABLES
- TABLE 1 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
- TABLE 2 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
- TABLE 3 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
- TABLE 4 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
- TABLE 5 LAMEA Assays & Kits Market by Country, 2019 - 2022, USD Million
- TABLE 6 LAMEA Assays & Kits Market by Country, 2023 - 2030, USD Million
- TABLE 7 LAMEA Instruments & Analyzers Market by Country, 2019 - 2022, USD Million
- TABLE 8 LAMEA Instruments & Analyzers Market by Country, 2023 - 2030, USD Million
- TABLE 9 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
- TABLE 10 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
- TABLE 11 LAMEA Diagnostic Laboratories Market by Country, 2019 - 2022, USD Million
- TABLE 12 LAMEA Diagnostic Laboratories Market by Country, 2023 - 2030, USD Million
- TABLE 13 LAMEA Hospitals & Clinics Market by Country, 2019 - 2022, USD Million
- TABLE 14 LAMEA Hospitals & Clinics Market by Country, 2023 - 2030, USD Million
- TABLE 15 LAMEA Others Market by Country, 2019 - 2022, USD Million
- TABLE 16 LAMEA Others Market by Country, 2023 - 2030, USD Million
- TABLE 17 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
- TABLE 18 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
- TABLE 19 LAMEA Lab Tests Market by Country, 2019 - 2022, USD Million
- TABLE 20 LAMEA Lab Tests Market by Country, 2023 - 2030, USD Million
- TABLE 21 LAMEA PoC Tests Market by Country, 2019 - 2022, USD Million
- TABLE 22 LAMEA PoC Tests Market by Country, 2023 - 2030, USD Million
- TABLE 23 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
- TABLE 24 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
- TABLE 25 LAMEA Isothermal Nucleic Acid Amplification Technology Market by Country, 2019 - 2022, USD Million
- TABLE 26 LAMEA Isothermal Nucleic Acid Amplification Technology Market by Country, 2023 - 2030, USD Million
- TABLE 27 LAMEA Polymerase Chain Reaction Market by Country, 2019 - 2022, USD Million
- TABLE 28 LAMEA Polymerase Chain Reaction Market by Country, 2023 - 2030, USD Million
- TABLE 29 LAMEA Immunodiagnostics Market by Country, 2019 - 2022, USD Million
- TABLE 30 LAMEA Immunodiagnostics Market by Country, 2023 - 2030, USD Million
- TABLE 31 LAMEA Others Market by Country, 2019 - 2022, USD Million
- TABLE 32 LAMEA Others Market by Country, 2023 - 2030, USD Million
- TABLE 33 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Country, 2019 - 2022, USD Million
- TABLE 34 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Country, 2023 - 2030, USD Million
- TABLE 35 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
- TABLE 36 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
- TABLE 37 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
- TABLE 38 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
- TABLE 39 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
- TABLE 40 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
- TABLE 41 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
- TABLE 42 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
- TABLE 43 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
- TABLE 44 Brazil Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
- TABLE 45 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
- TABLE 46 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
- TABLE 47 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
- TABLE 48 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
- TABLE 49 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
- TABLE 50 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
- TABLE 51 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
- TABLE 52 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
- TABLE 53 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
- TABLE 54 Argentina Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
- TABLE 55 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
- TABLE 56 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
- TABLE 57 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
- TABLE 58 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
- TABLE 59 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
- TABLE 60 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
- TABLE 61 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
- TABLE 62 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
- TABLE 63 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
- TABLE 64 UAE Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
- TABLE 65 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
- TABLE 66 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
- TABLE 67 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
- TABLE 68 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
- TABLE 69 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
- TABLE 70 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
- TABLE 71 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
- TABLE 72 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
- TABLE 73 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
- TABLE 74 Saudi Arabia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
- TABLE 75 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
- TABLE 76 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
- TABLE 77 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
- TABLE 78 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
- TABLE 79 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
- TABLE 80 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
- TABLE 81 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
- TABLE 82 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
- TABLE 83 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
- TABLE 84 South Africa Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
- TABLE 85 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
- TABLE 86 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
- TABLE 87 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
- TABLE 88 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
- TABLE 89 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
- TABLE 90 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
- TABLE 91 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
- TABLE 92 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
- TABLE 93 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
- TABLE 94 Nigeria Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
- TABLE 95 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
- TABLE 96 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
- TABLE 97 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
- TABLE 98 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
- TABLE 99 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
- TABLE 100 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
- TABLE 101 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
- TABLE 102 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
- TABLE 103 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
- TABLE 104 Rest of LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
- TABLE 105 Key Information - Abbott Laboratories
- TABLE 106 Key information - Becton, Dickinson and Company
- TABLE 107 Key Information - ZeptoMetrix LLC
- TABLE 108 Key Information - Danaher Corporation
- TABLE 109 Key Information - F. Hoffmann-La Roche Ltd.
- TABLE 110 Key Information - Hologic, Inc.
- TABLE 111 Key Information - Thermo Fisher Scientific, Inc.
- TABLE 112 Key Information - Bayer AG
- TABLE 113 Key Information - Qiagen N.V.
- TABLE 114 Key Information - Siemens AG
List of Figures
- FIG 1 Methodology for the research
- FIG 2 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2030, USD Million
- FIG 3 Key Impacting Factors chlamydia trachomatis/neisseria gonorrhoeae (CT/NG) testing market
- FIG 4 Porter's Five Forces Analysis - Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
- FIG 5 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by Product, 2022
- FIG 6 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by Product, 2030
- FIG 7 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2030, USD Million
- FIG 8 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by End User, 2022
- FIG 9 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by End User, 2030
- FIG 10 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2030, USD Million
- FIG 11 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by Testing Type, 2022
- FIG 12 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by Testing Type, 2030
- FIG 13 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2030, USD Million
- FIG 14 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by Technology, 2022
- FIG 15 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by Technology, 2030
- FIG 16 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2030, USD Million
- FIG 17 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by Country, 2022
- FIG 18 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by Country, 2030
- FIG 19 LAMEA Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Country, 2019 - 2030, USD Million
- FIG 20 SWOT Analysis: Abbott Laboratories
- FIG 21 SWOT Analysis: Becton, Dickinson and company
- FIG 22 SWOT Analysis: Becton, Dickinson and company
- FIG 23 SWOT Analysis: Danaher Corporation
- FIG 24 Swot Analysis: F. Hoffmann-La Roche Ltd.
- FIG 25 Swot Analysis: Hologic, Inc.
- FIG 26 Swot Analysis: Thermo Fisher Scientific, Inc.
- FIG 27 Swot Analysis: Bayer AG
- FIG 28 Swot Analysis: Qiagen N.V.
- FIG 29 SWOT Analysis: Siemens AG
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.